In a suspected case of CPT II deficiency the following are considered: (1) dextrose infusion to prevent catabolism till special milk feeds can be arranged, (2) a high carbohydrate and low-fat diet to provide substrate for glycolysis, (3) avoidance of known triggers, e.g., fasting, illness etc., (4) urgent IEM screen/genetic testing/echocardiography/and ultrasound scan of the brain and kidneys, (5) MCT supplementation, (6) intensive care monitoring, and (7) a multidisciplinary team including metabolic specialists and palliative care doctors
Do not use areas that appear bruised, red, scarred, or firm
What Science Says About Your Risk
[16] GLP-1 endogenous in humans [16] glucagon endogenous in humans [16] oxyntomodulin amycretin/ zenagamtide UBT251 exendin-4 [16] [17] exenatide lixisenatide [16] albiglutide beinaglutide dulaglutide efpeglenatide langlenatide liraglutide [16] polyethylene glycol/PEG- loxenatide semaglutide taspoglutide ecnoglutide utreglutide glepaglutide apraglutide maridebart cafraglutide tirzepatide pegapamodutide mazdutide survodutide bamadutide pemvidutide cotadutide retatrutide Lithium chloride Cinchonine grutalumab dapiglutide DA1726 GX-G6 GZR18 HRS9531/ KAI-9531/ Ribupatide PB718 RAY1225 VCT220 VK2735 BLX7006 supaglutide/ efsubaglutide ASC30 HRS7535 Danuglipron Aleniglipron Lotiglipron Orforglipron (non peptide partial agonist) [18] Conveglipron Elecoglipron/ AZD 5004/ ECC 5004 CT-996 CT-388/ Enicepatide CT-868 HEC88473 HS-10535 UBT251 efinopegdutide efocipegtrutide Berobenatide NNC9204-1706 TG103 YP05002/YP-05002 Positive Negative Clinical significance [edit] GLP-1 receptor agonists are a class of medications that mimic the actions of the endogenous incretin hormone GLP-1, and are used in type 2 diabetes and obesity
David Majure, MD, MPH, medical director of the Heart Transplant Service at Weill Cornell Medicine, spoke about the significant cardiovascular benefits of GLP-1RAs on a recent podcast
In conclusion, both BPC 157 and PRP show promise in the treatment of tendinitis and joint pain
